img

Global Personalized Cell Therapy Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Personalized Cell Therapy Market Research Report 2024

The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics.The personalized cell therapy is mainly developed for the treatment of high unmet need disease
According to MRAResearch’s new survey, global Personalized Cell Therapy market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Personalized Cell Therapy market research.
Key companies engaged in the Personalized Cell Therapy industry include Novartis AG, Vericel Corporation, Bellicum Pharmaceuticals, MolMed SpA, Cytori Therapeutics Inc, Gilead Sciences, Inc, Celgene Corporation, Bluebird Bio and Aurora Biopharma Inc, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Personalized Cell Therapy were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Personalized Cell Therapy market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Personalized Cell Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis AG
Vericel Corporation
Bellicum Pharmaceuticals
MolMed SpA
Cytori Therapeutics Inc
Gilead Sciences, Inc
Celgene Corporation
Bluebird Bio
Aurora Biopharma Inc
Saneron CCEL Therapeutics,Inc
Kuur Therapeutics
MediGene AG
Sangamo Therapeutics
Segment by Type
By Cell Type
Hematopoietic Stem Cell
Skeletal Muscle Stem Cell
Mesenchymal Stem Cells
Lymphocytes
Others
By Technique
Platelet Transfusions
Bone Marrow Transplantation
Packed Red Cell Transfusions
Organ Transplantation

Segment by Application


Cardiovascular Diseases
Neurological Disorders
Inflammatory Diseases
Diabetes
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Personalized Cell Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis By Cell Type
1.2.1 Global Personalized Cell Therapy Market Size Growth Rate By Cell Type: 2018 VS 2022 VS 2033
1.2.2 Hematopoietic Stem Cell
1.2.3 Skeletal Muscle Stem Cell
1.2.4 Mesenchymal Stem Cells
1.2.5 Lymphocytes
1.2.6 Others
1.3 Market by Application
1.3.1 Global Personalized Cell Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cardiovascular Diseases
1.3.3 Neurological Disorders
1.3.4 Inflammatory Diseases
1.3.5 Diabetes
1.3.6 Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cell Therapy Market Perspective (2018-2033)
2.2 Personalized Cell Therapy Growth Trends by Region
2.2.1 Global Personalized Cell Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Personalized Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Personalized Cell Therapy Forecasted Market Size by Region (2024-2033)
2.3 Personalized Cell Therapy Market Dynamics
2.3.1 Personalized Cell Therapy Industry Trends
2.3.2 Personalized Cell Therapy Market Drivers
2.3.3 Personalized Cell Therapy Market Challenges
2.3.4 Personalized Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cell Therapy Players by Revenue
3.1.1 Global Top Personalized Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global Personalized Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Personalized Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Cell Therapy Revenue
3.4 Global Personalized Cell Therapy Market Concentration Ratio
3.4.1 Global Personalized Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cell Therapy Revenue in 2022
3.5 Personalized Cell Therapy Key Players Head office and Area Served
3.6 Key Players Personalized Cell Therapy Product Solution and Service
3.7 Date of Enter into Personalized Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cell Therapy Breakdown Data by Type
4.1 Global Personalized Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Personalized Cell Therapy Forecasted Market Size by Type (2024-2033)
5 Personalized Cell Therapy Breakdown Data by Application
5.1 Global Personalized Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Personalized Cell Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Personalized Cell Therapy Market Size (2018-2033)
6.2 North America Personalized Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Personalized Cell Therapy Market Size by Country (2018-2023)
6.4 North America Personalized Cell Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Cell Therapy Market Size (2018-2033)
7.2 Europe Personalized Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Personalized Cell Therapy Market Size by Country (2018-2023)
7.4 Europe Personalized Cell Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cell Therapy Market Size (2018-2033)
8.2 Asia-Pacific Personalized Cell Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Personalized Cell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Personalized Cell Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Cell Therapy Market Size (2018-2033)
9.2 Latin America Personalized Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Personalized Cell Therapy Market Size by Country (2018-2023)
9.4 Latin America Personalized Cell Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cell Therapy Market Size (2018-2033)
10.2 Middle East & Africa Personalized Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Personalized Cell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Personalized Cell Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Personalized Cell Therapy Introduction
11.1.4 Novartis AG Revenue in Personalized Cell Therapy Business (2018-2023)
11.1.5 Novartis AG Recent Development
11.2 Vericel Corporation
11.2.1 Vericel Corporation Company Detail
11.2.2 Vericel Corporation Business Overview
11.2.3 Vericel Corporation Personalized Cell Therapy Introduction
11.2.4 Vericel Corporation Revenue in Personalized Cell Therapy Business (2018-2023)
11.2.5 Vericel Corporation Recent Development
11.3 Bellicum Pharmaceuticals
11.3.1 Bellicum Pharmaceuticals Company Detail
11.3.2 Bellicum Pharmaceuticals Business Overview
11.3.3 Bellicum Pharmaceuticals Personalized Cell Therapy Introduction
11.3.4 Bellicum Pharmaceuticals Revenue in Personalized Cell Therapy Business (2018-2023)
11.3.5 Bellicum Pharmaceuticals Recent Development
11.4 MolMed SpA
11.4.1 MolMed SpA Company Detail
11.4.2 MolMed SpA Business Overview
11.4.3 MolMed SpA Personalized Cell Therapy Introduction
11.4.4 MolMed SpA Revenue in Personalized Cell Therapy Business (2018-2023)
11.4.5 MolMed SpA Recent Development
11.5 Cytori Therapeutics Inc
11.5.1 Cytori Therapeutics Inc Company Detail
11.5.2 Cytori Therapeutics Inc Business Overview
11.5.3 Cytori Therapeutics Inc Personalized Cell Therapy Introduction
11.5.4 Cytori Therapeutics Inc Revenue in Personalized Cell Therapy Business (2018-2023)
11.5.5 Cytori Therapeutics Inc Recent Development
11.6 Gilead Sciences, Inc
11.6.1 Gilead Sciences, Inc Company Detail
11.6.2 Gilead Sciences, Inc Business Overview
11.6.3 Gilead Sciences, Inc Personalized Cell Therapy Introduction
11.6.4 Gilead Sciences, Inc Revenue in Personalized Cell Therapy Business (2018-2023)
11.6.5 Gilead Sciences, Inc Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Detail
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Personalized Cell Therapy Introduction
11.7.4 Celgene Corporation Revenue in Personalized Cell Therapy Business (2018-2023)
11.7.5 Celgene Corporation Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Detail
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Personalized Cell Therapy Introduction
11.8.4 Bluebird Bio Revenue in Personalized Cell Therapy Business (2018-2023)
11.8.5 Bluebird Bio Recent Development
11.9 Aurora Biopharma Inc
11.9.1 Aurora Biopharma Inc Company Detail
11.9.2 Aurora Biopharma Inc Business Overview
11.9.3 Aurora Biopharma Inc Personalized Cell Therapy Introduction
11.9.4 Aurora Biopharma Inc Revenue in Personalized Cell Therapy Business (2018-2023)
11.9.5 Aurora Biopharma Inc Recent Development
11.10 Saneron CCEL Therapeutics,Inc
11.10.1 Saneron CCEL Therapeutics,Inc Company Detail
11.10.2 Saneron CCEL Therapeutics,Inc Business Overview
11.10.3 Saneron CCEL Therapeutics,Inc Personalized Cell Therapy Introduction
11.10.4 Saneron CCEL Therapeutics,Inc Revenue in Personalized Cell Therapy Business (2018-2023)
11.10.5 Saneron CCEL Therapeutics,Inc Recent Development
11.11 Kuur Therapeutics
11.11.1 Kuur Therapeutics Company Detail
11.11.2 Kuur Therapeutics Business Overview
11.11.3 Kuur Therapeutics Personalized Cell Therapy Introduction
11.11.4 Kuur Therapeutics Revenue in Personalized Cell Therapy Business (2018-2023)
11.11.5 Kuur Therapeutics Recent Development
11.12 MediGene AG
11.12.1 MediGene AG Company Detail
11.12.2 MediGene AG Business Overview
11.12.3 MediGene AG Personalized Cell Therapy Introduction
11.12.4 MediGene AG Revenue in Personalized Cell Therapy Business (2018-2023)
11.12.5 MediGene AG Recent Development
11.13 Sangamo Therapeutics
11.13.1 Sangamo Therapeutics Company Detail
11.13.2 Sangamo Therapeutics Business Overview
11.13.3 Sangamo Therapeutics Personalized Cell Therapy Introduction
11.13.4 Sangamo Therapeutics Revenue in Personalized Cell Therapy Business (2018-2023)
11.13.5 Sangamo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Personalized Cell Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Hematopoietic Stem Cell
Table 3. Key Players of Skeletal Muscle Stem Cell
Table 4. Key Players of Mesenchymal Stem Cells
Table 5. Key Players of Lymphocytes
Table 6. Key Players of Others
Table 7. Global Personalized Cell Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Personalized Cell Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Personalized Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Personalized Cell Therapy Market Share by Region (2018-2023)
Table 11. Global Personalized Cell Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Personalized Cell Therapy Market Share by Region (2024-2033)
Table 13. Personalized Cell Therapy Market Trends
Table 14. Personalized Cell Therapy Market Drivers
Table 15. Personalized Cell Therapy Market Challenges
Table 16. Personalized Cell Therapy Market Restraints
Table 17. Global Personalized Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Personalized Cell Therapy Market Share by Players (2018-2023)
Table 19. Global Top Personalized Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cell Therapy as of 2022)
Table 20. Ranking of Global Top Personalized Cell Therapy Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Personalized Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Personalized Cell Therapy Product Solution and Service
Table 24. Date of Enter into Personalized Cell Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Personalized Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Personalized Cell Therapy Revenue Market Share by Type (2018-2023)
Table 28. Global Personalized Cell Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Personalized Cell Therapy Revenue Market Share by Type (2024-2033)
Table 30. Global Personalized Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Personalized Cell Therapy Revenue Market Share by Application (2018-2023)
Table 32. Global Personalized Cell Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Personalized Cell Therapy Revenue Market Share by Application (2024-2033)
Table 34. North America Personalized Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Personalized Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Personalized Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Personalized Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Personalized Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Personalized Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Personalized Cell Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Personalized Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Personalized Cell Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Personalized Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Personalized Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Personalized Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Personalized Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Personalized Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Personalized Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 49. Novartis AG Company Detail
Table 50. Novartis AG Business Overview
Table 51. Novartis AG Personalized Cell Therapy Product
Table 52. Novartis AG Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 53. Novartis AG Recent Development
Table 54. Vericel Corporation Company Detail
Table 55. Vericel Corporation Business Overview
Table 56. Vericel Corporation Personalized Cell Therapy Product
Table 57. Vericel Corporation Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 58. Vericel Corporation Recent Development
Table 59. Bellicum Pharmaceuticals Company Detail
Table 60. Bellicum Pharmaceuticals Business Overview
Table 61. Bellicum Pharmaceuticals Personalized Cell Therapy Product
Table 62. Bellicum Pharmaceuticals Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 63. Bellicum Pharmaceuticals Recent Development
Table 64. MolMed SpA Company Detail
Table 65. MolMed SpA Business Overview
Table 66. MolMed SpA Personalized Cell Therapy Product
Table 67. MolMed SpA Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 68. MolMed SpA Recent Development
Table 69. Cytori Therapeutics Inc Company Detail
Table 70. Cytori Therapeutics Inc Business Overview
Table 71. Cytori Therapeutics Inc Personalized Cell Therapy Product
Table 72. Cytori Therapeutics Inc Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 73. Cytori Therapeutics Inc Recent Development
Table 74. Gilead Sciences, Inc Company Detail
Table 75. Gilead Sciences, Inc Business Overview
Table 76. Gilead Sciences, Inc Personalized Cell Therapy Product
Table 77. Gilead Sciences, Inc Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 78. Gilead Sciences, Inc Recent Development
Table 79. Celgene Corporation Company Detail
Table 80. Celgene Corporation Business Overview
Table 81. Celgene Corporation Personalized Cell Therapy Product
Table 82. Celgene Corporation Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 83. Celgene Corporation Recent Development
Table 84. Bluebird Bio Company Detail
Table 85. Bluebird Bio Business Overview
Table 86. Bluebird Bio Personalized Cell Therapy Product
Table 87. Bluebird Bio Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 88. Bluebird Bio Recent Development
Table 89. Aurora Biopharma Inc Company Detail
Table 90. Aurora Biopharma Inc Business Overview
Table 91. Aurora Biopharma Inc Personalized Cell Therapy Product
Table 92. Aurora Biopharma Inc Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 93. Aurora Biopharma Inc Recent Development
Table 94. Saneron CCEL Therapeutics,Inc Company Detail
Table 95. Saneron CCEL Therapeutics,Inc Business Overview
Table 96. Saneron CCEL Therapeutics,Inc Personalized Cell Therapy Product
Table 97. Saneron CCEL Therapeutics,Inc Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 98. Saneron CCEL Therapeutics,Inc Recent Development
Table 99. Kuur Therapeutics Company Detail
Table 100. Kuur Therapeutics Business Overview
Table 101. Kuur Therapeutics Personalized Cell Therapy Product
Table 102. Kuur Therapeutics Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 103. Kuur Therapeutics Recent Development
Table 104. MediGene AG Company Detail
Table 105. MediGene AG Business Overview
Table 106. MediGene AG Personalized Cell Therapy Product
Table 107. MediGene AG Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 108. MediGene AG Recent Development
Table 109. Sangamo Therapeutics Company Detail
Table 110. Sangamo Therapeutics Business Overview
Table 111. Sangamo Therapeutics Personalized Cell Therapy Product
Table 112. Sangamo Therapeutics Revenue in Personalized Cell Therapy Business (2018-2023) & (US$ Million)
Table 113. Sangamo Therapeutics Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Cell Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Personalized Cell Therapy Market Share by Type: 2022 VS 2033
Figure 3. Hematopoietic Stem Cell Features
Figure 4. Skeletal Muscle Stem Cell Features
Figure 5. Mesenchymal Stem Cells Features
Figure 6. Lymphocytes Features
Figure 7. Others Features
Figure 8. Global Personalized Cell Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Personalized Cell Therapy Market Share by Application: 2022 VS 2033
Figure 10. Cardiovascular Diseases Case Studies
Figure 11. Neurological Disorders Case Studies
Figure 12. Inflammatory Diseases Case Studies
Figure 13. Diabetes Case Studies
Figure 14. Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Personalized Cell Therapy Report Years Considered
Figure 17. Global Personalized Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global Personalized Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global Personalized Cell Therapy Market Share by Region: 2022 VS 2033
Figure 20. Global Personalized Cell Therapy Market Share by Players in 2022
Figure 21. Global Top Personalized Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cell Therapy as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Personalized Cell Therapy Revenue in 2022
Figure 23. North America Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America Personalized Cell Therapy Market Share by Country (2018-2033)
Figure 25. United States Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Personalized Cell Therapy Market Share by Country (2018-2033)
Figure 29. Germany Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Personalized Cell Therapy Market Share by Region (2018-2033)
Figure 37. China Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Personalized Cell Therapy Market Share by Country (2018-2033)
Figure 45. Mexico Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Personalized Cell Therapy Market Share by Country (2018-2033)
Figure 49. Turkey Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia Personalized Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Novartis AG Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 52. Vericel Corporation Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 53. Bellicum Pharmaceuticals Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 54. MolMed SpA Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 55. Cytori Therapeutics Inc Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 56. Gilead Sciences, Inc Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 57. Celgene Corporation Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 58. Bluebird Bio Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 59. Aurora Biopharma Inc Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 60. Saneron CCEL Therapeutics,Inc Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 61. Kuur Therapeutics Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 62. MediGene AG Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 63. Sangamo Therapeutics Revenue Growth Rate in Personalized Cell Therapy Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed